Traders should no longer expect any further trading in PRA as shares have been suspended and delisting is imminent. Any remaining positions should be tendered or held solely for the $25.00 cash consideration. No arbitrage or post-merger trading opportunity exists beyond the settlement of the cash payment.
Price Chart
Executive Summary
ProAssurance Corp (PRA) filed a Form 25-NSE after completing its all-cash acquisition by The Doctors Company. Each PRA share was converted into $25.00 in cash, and NYSE has initiated delisting effective July 7, 2026. This filing formalizes the company's removal from listing and registration, marking the end of PRA as a public entity.
Key Facts
- ProAssurance merged with a subsidiary of The Doctors Company in an all-cash transaction
- Each share of PRA common stock converted to $25.00 in cash, without interest
- Merger closed and became effective before market open on June 26, 2026
- NYSE filed 25-NSE to delist PRA effective July 7, 2026
- PRA will be deregistered under the Exchange Act, becoming a wholly owned subsidiary of The Doctors Company
- Trading in PRA common stock was suspended on June 26, 2026
Financial Impact
Shareholders receive $25.00 per share in cash, representing the full value of the merger consideration. No ongoing equity interest remains in the public company.
Risk Factors
- Post-merger litigation or delays in cash payment could arise, though unlikely given closing has occurred
- Shareholders who did not tender may need to follow merger procedures to receive the $25.00 cash consideration
- No upside or downside beyond the $25.00 per share cash consideration
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0000876661-26-000573 |
| Document: 0000876661-26-000573-index.html | 0000876661-26-000573 |
| Document: 0000876661-26-000573.txt | 0000876661-26-000573 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 6, 2026 12w ago | 15-12G | $25.00 awaiting T+20 | awaiting T+20 | โ | $22.12 (โ11.52%) |
Jun 26, 2026 14w ago | 25-NSE | $24.99 awaiting T+20 | awaiting T+20 | โ | $22.12 (โ11.48%) |
Jun 26, 2026 14w ago | 8-K | $24.99 awaiting T+20 | awaiting T+20 | โ | $22.12 (โ11.48%) |
Jun 2, 2026 17w ago | 8-K | $24.42 $25.00 | โฒ +2.38% | โฒ +3.37% | $22.12 (โ9.42%) |
Apr 8, 2026 25w ago | 10-K/A | $24.26 $24.60 | โฒ +1.40% | โผ โ6.17% | $22.12 (โ8.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access